A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2006
11/07/2006	US7132399 Mammalian cell surface DNA receptor
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132284 Adenovirus packaging cell lines
11/07/2006	US7132276 Human p51 genes and gene products thereof
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132233 using capture oligonucleotides, primers and probes derived from conserved regions of the West Nile virus genome
11/07/2006	US7132099 Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide
11/07/2006	CA2226436C Generation of immune responses to prostate-specific antigen (psa)
11/07/2006	CA2196780C A liposomal delivery system comprising cationic lipopolyamines and neutral lipids for delivery of biologically active agents
11/04/2006	CA2538208A1 Modulation of myostatin and use thereof in cell transplantation-based treatment of muscle disease
11/02/2006	WO2006116660A2 Methods of inhibiting a gpr23
11/02/2006	WO2006116392A2 Particle-containing complex porous materials
11/02/2006	WO2006116300A2 Methods of treating graft versus host disease
11/02/2006	WO2006116220A1 Use of adenoviral protein e1b-19k in degenerative disorders
11/02/2006	WO2006115951A2 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells
11/02/2006	WO2006115776A1 Rate control during af using cellular intervention to modulate av node
11/02/2006	WO2006115547A2 Dendritic polymers with enhanced amplification and interior functionality
11/02/2006	WO2006115279A1 Composition for preservation of vascular endothelium
11/02/2006	WO2006086496A3 Stem cell-derived factors for treating pathologic conditions
11/02/2006	WO2006072809A3 Formulations that optimize intracellular concentration of nicotinamide adenine (nad+) and methods of use to protect cells and treat diseases and conditions
11/02/2006	WO2006040357A3 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/02/2006	WO2006031467A3 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
11/02/2006	WO2005110493A8 Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
11/02/2006	WO2005060479A3 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same
11/02/2006	WO2004096996A3 Modulation of glucagon receptor expression
11/02/2006	WO2003072715A3 Gasp1: a follistatin domain containing protein
11/02/2006	US20060248606 Mouse model for hepatitis C
11/02/2006	US20060248605 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
11/02/2006	US20060248601 Modification of organelle metabolism by unc-51-like kinases roma1 or 2tm proteins
11/02/2006	US20060247252 Augmented cognitive training
11/02/2006	US20060247202 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/02/2006	US20060247201 using an exogenously-derived colony-stimulating factor 5 hyaluronidase (CSF5hyaluronidase) for treatment of myelosuppression as may occur after irradiation, chemotherapy or other diseases where an increase in leukocyte levels may be beneficial
11/02/2006	US20060247200 Methods and uses of leukotriene B4 hydroxylases to treat diseases
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247198 TGF-beta type receptor cDNAs encoded products and uses therefor
11/02/2006	US20060247197 Method for down-regulating gene expression in fungi
11/02/2006	US20060247196 Yeast genes that affect viral replication
11/02/2006	US20060247195 Method of altering cell properties by administering rna
11/02/2006	US20060247194 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
11/02/2006	US20060247193 Regulation of gene expression by dna interference
11/02/2006	US20060247192 Control of apoptosis
11/02/2006	US20060247191 Chimeric cytoplasmic signalling molecules
11/02/2006	US20060247190 Compositions and methods for treating human papillomavirus mediated disease
11/02/2006	US20060247160 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension
11/02/2006	US20060246588 Modified zinc finger binding proteins
11/02/2006	US20060246587 Methods for transfecting T cells
11/02/2006	US20060246586 Chromosome-based platforms
11/02/2006	US20060246585 Nucleic acid complex and method of introducing nucleic acid into cell using the same
11/02/2006	US20060246569 Packaging systems for human recombinant adenovirus to be used in gene therapy
11/02/2006	US20060246567 Modified zinc finger binding proteins
11/02/2006	US20060246548 CE7-specific redirected immune cells
11/02/2006	US20060246517 Epitope protection assay
11/02/2006	US20060246505 Modulation of the synthesis of insulin
11/02/2006	US20060246491 Micro-RNA's that regulate muscle cells
11/02/2006	US20060246486 Human signal peptide-containing proteins
11/02/2006	US20060246452 Method for identifying nucleic acid molecules associated with angiogenesis
11/02/2006	US20060246448 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation
11/02/2006	US20060246433 Method and nucleic acids for the analysis of a colon cell proliferative disorder
11/02/2006	US20060246432 Methods and materials for modulating task-3
11/02/2006	US20060246422 Methods and compositions for use in spliceosome mediated RNA trans-splicing
11/02/2006	US20060246143 Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles
11/02/2006	US20060246140 Method for the preparation of molecular complexes
11/02/2006	US20060246138 Polyoxaester suspending vehicles for use with implantable delivery systems
11/02/2006	US20060246123 Oligonucleotide mimetics
11/02/2006	US20060246121 Particle-containing complex porous materials
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246091 Avidin-pseudotyped viral vectors and their use
11/02/2006	US20060246086 Virulence genes and proteins from Brucella melitensis, and their use
11/02/2006	US20060246074 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1- antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds
11/02/2006	US20060246065 Fail molecules and uses thereof
11/02/2006	US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab
11/02/2006	US20060246057 Treatment or prevention of damage due to radiation exposure
11/02/2006	US20060246044 Using electrical pulses and embryonic stem cell grafting to enhance cardiac tissue repair and nervous system regeneration; tissue engineering and repair; regenerative medicine
11/02/2006	US20060246043 Cellular preparation
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246038 Method of treating a disorder by suicide gene therapy
11/02/2006	US20060246037 Neuroprotective effects of atf6
11/02/2006	US20060246036 Delivery of therapeutics to the brain and spinal cord
11/02/2006	US20060246035 Methods and products related to treatment and prevention of hepatitis c virus infection
11/02/2006	US20060246024 Method for stimulating hair follicle cell proliferation
11/02/2006	EP1717315A2 Osteoprotegerin binding proteins and receptors
11/02/2006	EP1717248A1 Tumor targeted vector
11/02/2006	EP1717244A1 Akt activity specifically inhibiting polypeptide
11/02/2006	EP1716869A1 Drug for preventing or treating heart diseases comprising cd9 gene
11/02/2006	EP1716863A1 T cell immune response inhibitor
11/02/2006	EP1716234A1 Substituted, non-coding nucleic acid molecule used for the therapeutic and prophylactic immune stimulation in humans and higher animals
11/02/2006	EP1716174A2 Leucine rich repeat containing protein
11/02/2006	EP1716164A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
11/02/2006	EP1715971A1 Functionalized colloidal metal compositions and methods
11/02/2006	EP1715896A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer
11/02/2006	EP1355946B1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants
11/02/2006	EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them
11/02/2006	EP1261629B1 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1105157B1 Protein delivery system using human papillomavirus virus-like particles
11/02/2006	EP1003874B1 Neisseria lactoferrin binding protein
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	CA2605592A1 Rate control during af using cellular intervention to modulate av node
11/01/2006	CN1856576A Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
11/01/2006	CN1856508A Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity

1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 870